(Q41055870)

26 September 2017

1 reference

title

Antibody-interleukin 2 fusion proteins: a new approach to cancer therapy (English)

1 reference

26 September 2017

0 references

Reisfeld RA

1

1 reference

26 September 2017

Gillies SD

series ordinal

2

1 reference

26 September 2017

publication date

1 January 1996

1 reference

Journal of Clinical Laboratory Analysis

26 September 2017

published in

1 reference

26 September 2017

volume

10

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

160-166

1 reference

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Recombinant polymeric IgG: an approach to engineering more potent antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

21 January 2018

The cytokine wall chart

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Serum half-life and tumor localization of a chimeric antibody deleted of the CH2 domain and directed against the disialoganglioside GD2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Mechanisms of cellular cytotoxicity mediated by a recombinant antibody-IL2 fusion protein against human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2825%281996%2910%3A3%3C160%3A%3AAID-JCLA9%3E3.0.CO%3B2-F

10.1002/(SICI)1098-2825(1996)10:3<160::AID-JCLA9>3.0.CO;2-F

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference